Platform for Very Low-dose Potent Drug Products

• Technical advantages: separated containment facilities, highly effective and robust manufacturing process, very sensitive analytical methods for quantifying extremely low levels (ng-level) of impurities.

• More than 30 low dose potent products have been successfully commercialized, of which the lowest API content is only 0.004% in drug product.